CYP3A4 and hematologic disorder: Many drugs used in the treatment of hematologic malignancies, as well as immunosuppressants (e.g., cyclosporine, tacrolimus, and sirolimus), have significant drug–drug interactions with azoles, which are inhibitors of cytochrome P450-3A4 [132,137].